Английская Википедия:Isomorphic Labs

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox company

Шаблон:Use American English Шаблон:Use mdy dates

Isomorphic Labs Limited[1] is a London-based drug discovery company, which uses artificial intelligence for drug discovery.[2][3][4] Isomorphic Labs was founded by Demis Hassabis.[5][3] The company was incorporated on February 4, 2021 and announced on November 5, 2021.[2][6] It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind.[2][3][6] Hassabis is the CEO and founder.[3]

The company draws upon DeepMind's AlphaFold 2 technology, which can be used to predict protein structures in the human body with high accuracy, allowing its researchers to find new target pathways for drug delivery.[6][7]

In December 2022, Isomorphic Labs announced its second office location in Lausanne, Switzerland.[6][8]

In January 2024, Isomorphic Labs partnered with Novartis AG and Eli Lilly & Company to work together on AI drug discovery and research.[9]

References

Шаблон:Reflist

External links

Шаблон:Alphabet Inc.

Шаблон:Google-stub